US invests $5bn programme to launch next-gen Covid vaccines: Report

'Project Next Gen' would succeed 'Operation Warp Speed' with a mission to develop next-generation vaccines and therapies against newer and existing Covid variants, the Washington Post reported

covid 19 vaccine, coronavirus vaccine, vaccine, pharma, pharmaceutical industry
Photo: Bloomberg
IANS Washington
2 min read Last Updated : Apr 11 2023 | 9:00 PM IST

The US government has launched a $5 billion programme to accelerate the development of next-generation Covid-19 vaccines and treatments, according to media reports.

'Project Next Gen' would succeed 'Operation Warp Speed' with a mission to develop next-generation vaccines and therapies against newer and existing Covid variants, the Washington Post reported.

Operation Warp Speed, under then President Donald Trump, developed and distributed vaccines in the early days of the pandemic in 2020.

"While our vaccines are still very effective at preventing serious illness and death, they are less capable of reducing infections and transmission over time," a spokesperson from the US Department of Health and Human Services (HHS) was quoted as saying to the Post.

"New variants and loss of immunity over time could continue to challenge our healthcare systems in the coming years."

Project NextGen will cut across government agencies and involve public-private collaborations, a senior government official was quoted as saying to USA TODAY.

Current vaccines, developed rapidly in the heat of the emergency, are "really good, but they're not great," said Michael Osterholm, an epidemiologist who worked with the Joe Biden administration to develop the new programme.

"There is a substantial amount of work (to be done) to take these good vaccines and hopefully achieve better vaccines."

Project NextGen majorly aims to develop a nasal vaccine that will hopefully prevent infection as well as severe disease; develop longer-lasting vaccines; and create "broader" vaccines that protect against all variants and several different coronaviruses, the report said.

It will also include funding to develop more durable monoclonal antibodies resistant to new variants, according to the administration. Antibodies were highly effective treatments earlier in the pandemic but have not been able to keep up with the virus as it evolved and are no longer available.

According to the administration, the allocation of $5 billion will be financed through money saved from contracts costing less than originally estimated, the Post reported.

Meanwhile, US President Joe Biden on Monday officially ended the Covid national health emergency that for more than three years underpinned extraordinary efforts to provide care for a country where more than a million people died from the disease.

According to the White House, Biden signed a law passed earlier by Congress "which terminates the national emergency related to the Covid-19 pandemic."

This means closure of funding streams for Covid tests, free vaccines and other emergency measures.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :United StatesCoronavirus VaccineInvestment

First Published: Apr 11 2023 | 8:59 PM IST

Next Story